ArticleHereditary cancer in clinical practice2024

Benefits of osimertinib treat a lung adenocarcinoma patient with germline EGFR T790M, somatic EGFR 19-Del, TP53 and PIK3CA mutations.

Yingxue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.